Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
Trastuzumab increases the clinical benefit of first-line chemotherapy in metastatic breast cancer that overexpresses HER2.
Publications
View AllSoft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
individualised decision making with an informed patient. Careful follow-up is then recommended. (using regimens active in
The landscape of genomic alterations across childhood cancers
Pan-cancer analyses that examine commonalities and differences among various cancer types have emerged as a powerful way to obtain novel insights into cancer biology. Here we pr...
Institution Info
- Type
- healthcare
- Country
- DE
- Publications
- 3
- Citations
- 14,384
External Links
Identifiers
- ROR
- https://ror.org/01xet8208